<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25368826</article-id>
      <article-id pub-id-type="pmc">4215421</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2014.34.6.475</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="heading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Cryptic <italic>ETV6/ABL1</italic> Rearrangement Represents a Unique Fluorescence <italic>In Situ</italic> Hybridization Signal Pattern in a Patient with B Acute Lymphoblastic Leukemia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Ju Sun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Sang-Yong</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Seung-Tae</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hee-Jin</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Sun-Hee</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Sun-Hee Kim. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea. Tel: +82-2-3410-2704, Fax: +82-2-3410-2719, <email>sunnyhk@skku.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>10</month>
        <year>2014</year>
      </pub-date>
      <volume>34</volume>
      <issue>6</issue>
      <fpage>475</fpage>
      <lpage>477</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>12</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Although rearrangements involving each <italic>ETV6</italic> and <italic>ABL1</italic> gene are some of the most commonly observed chromosomal translocations in hematological malignancies [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>], an <italic>ETV6/ABL1</italic> rearrangement is very rare, and only 29 such cases have been reported to date [<xref rid="B3" ref-type="bibr">3</xref>]. This fusion has been associated with a wide range of hematological malignancies, including 11 cases of atypical chronic myeloid leukemia (<italic>BCR/ABL1</italic> negative), 3 cases of myeloproliferative neoplasm (MPN), 5 cases of acute myeloid leukemia, and 10 cases of ALL. The rarity of this rearrangement is related to the inverse transcriptional orientation of the 2 genes relative to the centromeres, because it would involve at least 2 events to form an in-frame fusion transcript [<xref rid="B3" ref-type="bibr">3</xref>]. Here, we report a case of B-ALL with <italic>ETV6/ABL1</italic> rearrangement.</p>
    <p>A 30-yr-old woman, 12 weeks pregnant with her second child, visited the Samsung Medical Center emergency room because of a complete blood count (CBC) abnormality detected at a referring hospital. She experienced cough and sore throat for 3 weeks prior to her visit, and headache, dyspnea, and tender gums occurred several days before presentation. A peripheral blood count revealed white blood cell counts 227.47&#xD7;10<sup>9</sup>/L with 85% blasts, hemoglobin 9.3 g/dL, platelet counts 39&#xD7;10<sup>9</sup>/L, and serum lactate dehydrogenase 2,316 U/L. Bone marrow aspirate smear revealed diffuse infiltration by lymphoblasts (75%), which expressed CD19, CD10, CD20, cCD22, cCD79a, HLA-DR, CD34, terminal deoxynucleotidyltransferase (TdT), and aberrant CD33; thus, the patient was diagnosed as having B-ALL. Conventional chromosome analysis of bone marrow cells indicated trisomy 5 as the sole abnormality in 19 of 20 metaphases analyzed. Multiplex reverse transcription (RT)-PCR indicated positivity for the 1,141-bp <italic>ETV6/ABL1</italic> type B fusion transcript (exons 1-5 of <italic>ETV6</italic> fused to exon 2 of <italic>ABL1</italic>) and also weak positivity for the type A fusion transcript (exons 1-4 of <italic>ETV6</italic> fused to exon 2 of <italic>ABL1</italic>). Sequence analysis of fusion transcripts using the Sanger method confirmed the fusion of <italic>ETV6</italic> exon 5 to <italic>ABL1</italic> exon 2, and the existence of 2 different transcripts, type A and B, was evidence for alternative splicing (<xref ref-type="fig" rid="F1">Fig. 1G</xref>).</p>
    <p>Since HemaVision (DNA Technology, Aarhus, Denmark) and Sanger sequencing had already revealed the <italic>ETV6/ABL1</italic> rearrangement, we performed FISH analysis using the following commercially available locus-specific identifiers (LSI): <italic>ETV6/RUNX1</italic> Extra Signal (ES), <italic>BCR/ABL</italic> Dual Fusion (DF), and <italic>ETV6</italic> Break Apart (BA) DNA probes (Abbott Vysis, Des Plaines, IL, USA). LSIs were used in both interphase and metaphase cells of bone marrow aspirate (<xref ref-type="fig" rid="F1">Fig. 1A-F</xref>). The <italic>BCR/ABL</italic> DF probe revealed interphase cells with 2 green signals for <italic>BCR</italic> and 3 orange signals for <italic>ABL1</italic>, suggesting a rearrangement of <italic>ABL1</italic>. The <italic>ETV6/RUNX1</italic> ES probe revealed 2 green and 2 orange signals for <italic>ETV6</italic> and <italic>RUNX1</italic>, respectively, with a third, albeit significantly smaller, <italic>ETV6</italic> signal. The <italic>ETV6</italic> BA probe revealed an additional orange signal for the 5' end of <italic>ETV6</italic> with 2 normal fusion signals. These results were different from what we had expected, since <italic>ETV6/ABL1</italic> rearrangement with a breakpoint at intron 5 of <italic>ETV6</italic> may not affect the <italic>ETV6</italic> signal, encompassing exons 1-5 of <italic>ETV6</italic> on the <italic>ETV6/RUNX1</italic> ES probe, and also may not produce split <italic>ETV6</italic> signals on the BA probe. Metaphase cell analysis revealed abnormal signals for <italic>BCR</italic> and <italic>ETV6</italic> on chromosomes 12 and 9, respectively.</p>
    <p>Collectively, these results indicate a fusion between <italic>ETV6</italic> and <italic>ABL1</italic> with inverse chromosomal orientation, which could occur via 2 events (<xref ref-type="fig" rid="F2">Fig. 2</xref>): 1) a balanced t(9;12)(q34;p13) results in the juxtaposition of part of <italic>ABL1</italic> (exons 2-10) in the vicinity upstream of <italic>ETV6</italic>, exon 1 at 12p13; followed by 2) an inversion within the 12p13 segment of der(12)t(9;12) after breakage at intron 5 of <italic>ETV6</italic>, and the boundary of the <italic>ABL1</italic> segment bordered by upstream of <italic>ETV6</italic>. The International System for Human Cytogenetic Nomenclature (ISCN) for the abnormal clone demonstrated by FISH is: 47,XX,+5. ish der(9)t(9;12)(q34;p13),der(12)t(9;12)(q34;p13)inv(12)(p13p13). The patient received induction chemotherapy and, after consolidation treatment, underwent allogenic peripheral blood stem cell transplantation; however, she experienced relapse of B-ALL 5 months after transplantation.</p>
    <p>There are various descriptions in the literature of in-frame fusion products involving <italic>ETV6</italic> and <italic>ABL1</italic> with varying orientations, but <italic>ETV6/ABL1</italic> rearrangement is often not detected using conventional chromosome analysis because of the cryptic nature of this rearrangement [<xref rid="B4" ref-type="bibr">4</xref>]. These cryptic rearrangements were also due to similar G banding patterns of the long arm of chromosome 9 and short arm of chromosome 12. RT-PCR screening for leukemia-related fusion transcripts (using methods such as HemaVision) is a useful tool to detect these cryptic rearrangements; however, this RT-PCR screening has been mainly performed in acute leukemia and not in other hematologic malignancies, such as MPN. Therefore, the frequency of <italic>ETV6/ABL1</italic> rearrangement among total hematologic malignancies is likely underestimated.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflicts of interest to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Braekeleer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Douet-Guilbert</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Le Bris</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Basinko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>De Braekeleer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title><italic>ETV6</italic> fusion genes in hematological malignancies: a review</article-title>
          <source>Leuk Res</source>
          <year>2012</year>
          <volume>36</volume>
          <fpage>945</fpage>
          <lpage>961</lpage>
          <pub-id pub-id-type="pmid">22578774</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Braekeleer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Douet-Guilbert</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bown</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Morel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Berthou</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>ABL1</italic> fusion genes in hematological malignancies: a review</article-title>
          <source>Eur J Haematol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>361</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">21435002</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gancheva</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Virchis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Howard-Reeves</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cross</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Brazma</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Myeloproliferative neoplasm with <italic>ETV6-ABL1</italic> fusion: a case report and literature review</article-title>
          <source>Mol Cytogenet</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>39</fpage>
          <pub-id pub-id-type="pmid">24053143</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Variant of <italic>ETV6/ABL1</italic> gene is associated with leukemia phenotype</article-title>
          <source>Acta Haematol</source>
          <year>2013</year>
          <volume>129</volume>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">23171811</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>FISH analysis using locus-specific identifiers for interphase and metaphase cells of bone marrow aspirate. (A) LSI <italic>ETV6/RUNX1</italic> (ES) probe on interphase cells, (B) LSI <italic>ETV6/RUNX1</italic> (ES) probe on metaphase cells, (C) LSI <italic>BCR/ABL1</italic> (DF) probe on interphase cells, (D) LSI <italic>BCR/ABL1</italic> (DF) probe on metaphase cells, (E) LSI <italic>ETV6</italic> (BA) probe on interphase cells, (F) LSI <italic>ETV6</italic> (BA) probe on metaphase cells, and (G) Sequence of fusion transcript products spanning the fusion site, revealing fusion of <italic>ETV6</italic> exon 5 to <italic>ABL1</italic> exon 2.</p>
        <p>Abbreviations: LSI, locus-specific identifier; DF, dual fusion; ES, extra signal; BA, break-apart.</p>
      </caption>
      <graphic xlink:href="alm-34-475-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Schematic representation of the suspected chromosomal mechanism leading to <italic>ETV6/ABL1</italic> rearrangement in this case.</p>
      </caption>
      <graphic xlink:href="alm-34-475-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
